<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00560859</url>
  </required_header>
  <id_info>
    <org_study_id>804695</org_study_id>
    <secondary_id>5U01HL083129-05</secondary_id>
    <nct_id>NCT00560859</nct_id>
  </id_info>
  <brief_title>Childhood Adenotonsillectomy Study for Children With OSAS</brief_title>
  <acronym>CHAT</acronym>
  <official_title>A Randomized Controlled Study of Adenotonsillectomy for Children With Obstructive Sleep Apnea Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Harvard University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to determine the effect of adenotonsillectomy surgery
      (removal of tonsils and adenoids) on obstructive sleep apnea syndrome (OSAS) in children.
      OSAS can cause health problems including poor growth, high blood pressure, diabetes and
      behavioral and learning difficulties. Although adenotonsillectomy is the usual treatment for
      children with OSAS, it is not known with any certainty if the child's OSAS symptoms improve
      afterwards. This study will help determine if improvement occurs or if it does not. It will
      also look at whether certain groups, such as children who are overweight or of different
      ethnicities, are helped by the surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Because adenotonsillectomy is the usual treatment for OSAS, all children in the study will
      get surgery. However, in order to assess the extent to which adenotonsillectomy surgery
      improves breathing disturbances and sleep quality in children with OSAS, two groups will be
      studied. One group will get surgery early (one month after enrollment) and the other group
      will be re-evaluated for surgery within 7 months of enrollment.

      Children in both groups will be closely monitored through the 7-8 month study period and
      sleep and health educational materials will be provided to assist in establishing healthy
      habits.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvements in Attention/Executive Domain Index of the Developmental Neuropsychological Assessment (NEPSY) From Baseline to 7 Months.</measure>
    <time_frame>The primary endpoint measure will occur at 7 months following the baseline visit.</time_frame>
    <description>The primary outcome was the change in the attention and executive function score on the NEPSY. The change from baseline in Attention/Executive Domain Index of the Developmental Neuropsychological Assessment (NEPSY) was compared to 7 months were compared. Scores on the attention and executive-function domain of the Developmental Neuropsychological Assessment (NEPSY) range from 50 to 150, with higher scores indicating better functioning.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Apnea Hypopnea Index (AHI) Score From Baseline to 7 Months</measure>
    <time_frame>7 months following the baseline visit.</time_frame>
    <description>The outcome measure was the change in AHI from baseline to 7 months to determine if there was an improvement in score is associated with improved OSAS (i.e reduction in AHI). The AHI is calculated by dividing the number of apnea events by the number of hours of sleep. The obstructive sleep apnea syndrome was defined as an AHI score of 2 or more events per hour or an obstructive apnea index (OAI) score of 1 or more events per hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Score of Pediatric Sleep Questionnaire Sleep-related Breathing Disorder Scale</measure>
    <time_frame>7 months following baseline.</time_frame>
    <description>Scores on the Pediatric Sleep Questionnaire sleep-related breathing disorder scale (PSQ-SRBD) range from 0 to 1, with higher scores indicating greater severity.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">453</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Snoring</condition>
  <arm_group>
    <arm_group_label>Early AT Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>There will be removal of tonsils and adenoids that will be performed within 4 weeks of the baseline visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Watchful Waiting</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Children will be closely monitored and re-evaluated for AT by an otolaryngologist after the primary 7 month monitoring period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adenotonsillectomy (AT) - removal of adenoids and tonsils</intervention_name>
    <description>Standard surgical intervention for treatment of Obstructive Sleep Apnea Syndrome which includes removal of adenoids and tonsils</description>
    <arm_group_label>Early AT Surgery</arm_group_label>
    <other_name>EAT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Watchful Waiting</intervention_name>
    <description>Children will reevaluated for adenotonsillectomy (AT) after a 7 month primary monitoring period.</description>
    <arm_group_label>Watchful Waiting</arm_group_label>
    <other_name>Watchful Waiting with Supportive Care (WWSC)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ages 5.0 to 9.99 years at time of screening.

          2. Diagnosed with Obstructive Sleep Apnea defined as: Obstructive Apnea Index (OAI) ≥ 1
             or Apnea Hypopnea Index (AHI) ≥ 2, confirmed on nocturnal, laboratory-based PSG and
             Parental report of habitual snoring (on average occurring &gt;3 nights per week).

          3. Tonsillar hypertrophy ≥ 1 based on a standardized scale of 0-4: 0 = surgically absent,
             1 = taking up &lt; 25% of the airway, 2 = 25 - 50 % of the airway,3 = 50 - 75 % of the
             airway, 4 = &gt; 75% of the airway

          4. Deemed to be a surgical candidate for AT by Ear, Nose and Throat specialist (ENT)
             evaluation.

        Exclusion Criteria:

          1. Recurrent tonsillitis defined as: &gt;3 episodes in each of 3 years, 5 episodes in each
             of 2 years, or 7 episodes in one year

          2. Craniofacial anomalies, including cleft lip and palate or sub-mucosal cleft palate or
             any anatomic or systemic condition which would interfere with general anesthesia or
             removal of tonsils and adenoid tissue in the standard fashion

          3. Obstructive breathing while awake that merits prompt AT in the opinion of the child's
             physician

          4. Severe OSAS or significant hypoxemia requiring immediate AT as defined by: OAI&gt;20 or
             AHI&gt;30, desaturation defined as oxygen saturation (SaO2) &lt;90% for more than 2% sleep
             time

          5. Apnea hypopnea indices in the normal range (OAI &lt; 1 and AHI &lt;2)

          6. Evidence of clinically significant cardiac arrhythmia on PSG: Non-sustained
             ventricular tachycardia Atrial fibrillation, Second degree atrioventricular (AV)
             block: Sustained bradycardia &lt; 40 bpm (&gt; 2 minutes, Sustained tachycardia &gt; 140 bpm (&gt;
             2 minutes)

          7. Extremely overweight defined as: body mass index &gt; 2.99 age group and sex-z-score

          8. Severe health problems that could be exacerbated by delayed treatment for OSAS
             Including: Doctor-diagnosed heart disease or cor pulmonale, history of Stage II
             Hypertension (HTN) defined as &gt; 99% percentile plus 5 mmHg for either systolic or
             diastolic, based on the age, gender, and height and/or requiring medication, therapy
             for failure to thrive or short stature, psychiatric or behavioral disorders requiring
             or likely to require initiation of new medication, therapy, or other specific
             treatment. School aged children, parental report of excessive daytime sleepiness
             defined as unable to maintain wakefulness, at least three times per week, in routine
             activities in school or home, despite adequate opportunity to sleep.

          9. Severe chronic health conditions that might hamper participation including: severe
             cardiopulmonary disorders, sickle cell anemia, poorly controlled asthma, epilepsy
             requiring medication, diabetes (type I or type II) requiring medication, conditions
             likely to preclude accurate polysomnography (e.g. severe uncontrolled pain),mental
             retardation or enrollment in a formal school Individual Educational Plan (IEP) and
             assigned to a self-contained classroom for all academic subjects, history of inability
             to complete cognitive testing and/or score on the Differential Ability Scale (DAS) II
             of ≤ 55, chronic infection or HIV

         10. Known genetic, craniofacial, neurological or psychiatric conditions likely to affect
             the airway, cognition, or behavior

         11. Current use of one or more of the following medications: psychotropics,
             hypnotics,hypoglycemic agents or insulin,antihypertensives,growth hormone,
             anticonvulsants,anti-coagulants,daily oral corticosteroids, daily medications for pain

         12. Previous upper airway surgery on the nose, pharynx or larynx, including tonsillectomy.
             Ear surgery and/or pressure equalizing (PE) tubes are not exclusion criteria

         13. Receives Continuous Positive Airway Pressure (CPAP) treatment

         14. A parent or guardian who cannot accompany the child on the night of polysomnogram
             (PSG)

         15. A family planning to move out of the area within the year

         16. Female participants only: Parental report that child has reached menarche
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>9 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Redline, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>Harvard University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susan Ellenberg, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ron Chervin, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruno Giordani, PH.D.</last_name>
    <role>Study Director</role>
    <affiliation>Univeristy of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susan Garetz, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raouf Amin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cincinnati Children's Hopsital Medical Center (CCHMC)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carole Marcus, MBB Ch.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Philadelphia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carol Rosen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Case University School of Medicine; Rainbow Babies &amp; Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ron Mitchell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardinal Glennon Children's Medical Center, St. Louis MO</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raanan Arens, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Children's Hospital Albert Einstein Med Ctr, NY NY</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hiren Muzumdar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Chilren's Hospital Albert Einstein Med Ctr, NY NY</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eliot Katz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children's Hospital, Boston MA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardinal Glennon Children's Medical Center</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Children's Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rainbow Babies &amp; Children's Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.nhlbi.nih.gov/about/ncsdr/</url>
    <description>National Center on Sleep Disorder Research</description>
  </link>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2007</study_first_submitted>
  <study_first_submitted_qc>November 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2007</study_first_posted>
  <results_first_submitted>July 13, 2015</results_first_submitted>
  <results_first_submitted_qc>November 10, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 15, 2015</results_first_posted>
  <last_update_submitted>November 10, 2015</last_update_submitted>
  <last_update_submitted_qc>November 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep disordered breathing</keyword>
  <keyword>Sleep apnea</keyword>
  <keyword>Tonsillectomy</keyword>
  <keyword>Adenoidectomy</keyword>
  <keyword>Snoring</keyword>
  <keyword>Neurobehavioral Manifestations</keyword>
  <keyword>Obstructive Sleep Apnea Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Snoring</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Children were recruited at 7 academic sleep centers. Early in the trial the investigator at one center relocated and that center was withdrawn.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Early AT Surgery</title>
          <description>Adenotonsillectomy (AT) - removal of tonsils and adenoids - performed within 4 weeks of the baseline visit.
Adenotonsillectomy (AT) - removal of adenoids and tonsils: Standard surgical intervention for treatment of Obstructive Sleep Apnea Syndrome.</description>
        </group>
        <group group_id="P2">
          <title>Watchful Waiting</title>
          <description>Children will be closely monitored during the primary 7 month monitoring period and will be re-evaluated for AT by an otolaryngologist at the end of that period. a
Watchful Waiting: Children will reevaluated for adenotonsillectomy (AT) after a 7 month primary monitoring period.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="226"/>
                <participants group_id="P2" count="227"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="194"/>
                <participants group_id="P2" count="203"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>These numbers represent all children randomized .</population>
      <group_list>
        <group group_id="B1">
          <title>Early AT Surgery</title>
          <description>Adenotonsillectomy (AT) - removal of tonsils and adenoids - performed within 4 weeks of the baseline visit.
Adenotonsillectomy (AT) - removal of adenoids and tonsils: Standard surgical intervention for treatment of Obstructive Sleep Apnea Syndrome.</description>
        </group>
        <group group_id="B2">
          <title>Watchful Waiting</title>
          <description>Children will be closely monitored and re-evaluated for AT by an otolaryngologist after the primary 7 month monitoring period.
Watchful Waiting: Children will reevaluated for adenotonsillectomy (AT) after a 7 month primary monitoring period.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="226"/>
            <count group_id="B2" value="227"/>
            <count group_id="B3" value="453"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.6" spread="1.4"/>
                    <measurement group_id="B2" value="6.5" spread="1.4"/>
                    <measurement group_id="B3" value="6.6" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="226"/>
                    <measurement group_id="B2" value="227"/>
                    <measurement group_id="B3" value="453"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="109"/>
                    <measurement group_id="B3" value="234"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                    <measurement group_id="B2" value="118"/>
                    <measurement group_id="B3" value="219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="123"/>
                    <measurement group_id="B3" value="249"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="210"/>
                    <measurement group_id="B2" value="206"/>
                    <measurement group_id="B3" value="416"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="226"/>
                    <measurement group_id="B2" value="227"/>
                    <measurement group_id="B3" value="453"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Improvements in Attention/Executive Domain Index of the Developmental Neuropsychological Assessment (NEPSY) From Baseline to 7 Months.</title>
        <description>The primary outcome was the change in the attention and executive function score on the NEPSY. The change from baseline in Attention/Executive Domain Index of the Developmental Neuropsychological Assessment (NEPSY) was compared to 7 months were compared. Scores on the attention and executive-function domain of the Developmental Neuropsychological Assessment (NEPSY) range from 50 to 150, with higher scores indicating better functioning.</description>
        <time_frame>The primary endpoint measure will occur at 7 months following the baseline visit.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early AT Surgery</title>
            <description>Adenotonsillectomy (AT) - removal of tonsils and adenoids - performed within 4 weeks of the baseline visit.
Adenotonsillectomy (AT) - removal of adenoids and tonsils: Standard surgical intervention for treatment of Obstructive Sleep Apnea Syndrome.</description>
          </group>
          <group group_id="O2">
            <title>Watchful Waiting</title>
            <description>Children will be closely monitored during the primary 7-month monitoring period and re-evaluated for AT by an otolaryngologist after that period.
Watchful Waiting: Children will reevaluated for adenotonsillectomy (AT) after a 7 month primary monitoring period.</description>
          </group>
        </group_list>
        <measure>
          <title>Improvements in Attention/Executive Domain Index of the Developmental Neuropsychological Assessment (NEPSY) From Baseline to 7 Months.</title>
          <description>The primary outcome was the change in the attention and executive function score on the NEPSY. The change from baseline in Attention/Executive Domain Index of the Developmental Neuropsychological Assessment (NEPSY) was compared to 7 months were compared. Scores on the attention and executive-function domain of the Developmental Neuropsychological Assessment (NEPSY) range from 50 to 150, with higher scores indicating better functioning.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="194"/>
                <count group_id="O2" value="203"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.1" spread="13.9"/>
                    <measurement group_id="O2" value="5.1" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.16</p_value>
            <method>ANCOVA</method>
            <param_type>difference of change from baseline</param_type>
            <param_value>2.0</param_value>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Apnea Hypopnea Index (AHI) Score From Baseline to 7 Months</title>
        <description>The outcome measure was the change in AHI from baseline to 7 months to determine if there was an improvement in score is associated with improved OSAS (i.e reduction in AHI). The AHI is calculated by dividing the number of apnea events by the number of hours of sleep. The obstructive sleep apnea syndrome was defined as an AHI score of 2 or more events per hour or an obstructive apnea index (OAI) score of 1 or more events per hour.</description>
        <time_frame>7 months following the baseline visit.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Early AT Surgery</title>
            <description>Adenotonsillectomy (AT) - removal of tonsils and adenoids - performed within 4 weeks of the baseline visit.
Adenotonsillectomy (AT) - removal of adenoids and tonsils: Standard surgical intervention for treatment of Obstructive Sleep Apnea Syndrome.</description>
          </group>
          <group group_id="O2">
            <title>Watchful Waiting</title>
            <description>Children will be closely monitored and re-evaluated for AT by an otolaryngologist after the primary 7 month monitoring period.
Watchful Waiting: Children will reevaluated for adenotonsillectomy (AT) after a 7 month primary monitoring period.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Apnea Hypopnea Index (AHI) Score From Baseline to 7 Months</title>
          <description>The outcome measure was the change in AHI from baseline to 7 months to determine if there was an improvement in score is associated with improved OSAS (i.e reduction in AHI). The AHI is calculated by dividing the number of apnea events by the number of hours of sleep. The obstructive sleep apnea syndrome was defined as an AHI score of 2 or more events per hour or an obstructive apnea index (OAI) score of 1 or more events per hour.</description>
          <units>Events per hour</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="194"/>
                <count group_id="O2" value="203"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.5" lower_limit="-7.1" upper_limit="-1.8"/>
                    <measurement group_id="O2" value="-1.6" lower_limit="-3.7" upper_limit="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Score of Pediatric Sleep Questionnaire Sleep-related Breathing Disorder Scale</title>
        <description>Scores on the Pediatric Sleep Questionnaire sleep-related breathing disorder scale (PSQ-SRBD) range from 0 to 1, with higher scores indicating greater severity.</description>
        <time_frame>7 months following baseline.</time_frame>
        <population>There was missing data for some children in the Watchful Waiting group since the Pediatric Sleep Questionnaire was not completed. Hence these numbers are not consistent with the rows in the participant flow module</population>
        <group_list>
          <group group_id="O1">
            <title>Early AT Surgery</title>
            <description>Adenotonsillectomy (AT) - removal of tonsils and adenoids - performed within 4 weeks of the baseline visit.
Adenotonsillectomy (AT) - removal of adenoids and tonsils: Standard surgical intervention for treatment of Obstructive Sleep Apnea Syndrome.</description>
          </group>
          <group group_id="O2">
            <title>Watchful Waiting</title>
            <description>Children will be closely monitored and re-evaluated for AT by an otolaryngologist after the primary 7 month monitoring period.
Watchful Waiting: Children will reevaluated for adenotonsillectomy (AT) after a 7 month primary monitoring period.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Score of Pediatric Sleep Questionnaire Sleep-related Breathing Disorder Scale</title>
          <description>Scores on the Pediatric Sleep Questionnaire sleep-related breathing disorder scale (PSQ-SRBD) range from 0 to 1, with higher scores indicating greater severity.</description>
          <population>There was missing data for some children in the Watchful Waiting group since the Pediatric Sleep Questionnaire was not completed. Hence these numbers are not consistent with the rows in the participant flow module</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="194"/>
                <count group_id="O2" value="202"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="0.2"/>
                    <measurement group_id="O2" value="0" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Reported adverse events include events starting from the initiation of any study procedures to the end of the study follow-up.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Early AT Surgery</title>
          <description>Adenotonsillectomy (AT) - removal of tonsils and adenoids - performed within 4 weeks of the baseline visit.
Adenotonsillectomy (AT) - removal of adenoids and tonsils: Standard surgical intervention for treatment of Obstructive Sleep Apnea Syndrome.</description>
        </group>
        <group group_id="E2">
          <title>Watchful Waiting</title>
          <description>Children will be closely monitored and re-evaluated for AT by an otolaryngologist after the primary 7 month monitoring period.
Watchful Waiting: Children will reevaluated for adenotonsillectomy (AT) after a 7 month primary monitoring period.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="226"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Vomitting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Application site pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Pleural Effusion (non-malignant)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Tonsillar haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="166" subjects_at_risk="226"/>
                <counts group_id="E2" subjects_affected="227" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear Pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>External ear infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>precocious puberty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Conjuctivits</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Eye Allergy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Breath Odor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Stomach discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Vomitting</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="226"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Application site bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Application site rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>fatigue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>fever (in the absence of neutropenia, where neutropenia is defined as anc &lt;1.0 x 10e9/l)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>influenza like illness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy to sting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>multiple allergies</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Seasonal Allergy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Acute Sinusitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Adenoviral upper respiratory infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Body Tinea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Croup Infectious</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Ear Infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="226"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Ear Infection Baceterial</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="226"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Febrile infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Gastroenteritis adenovirus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>gastroenteritis viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Hand-foot-and-mouth disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>hordeolum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>infected insect bite</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>influenza</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Lice infestation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Nail Tinea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>nasopharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="226"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Otitis media bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="226"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>pharyngitis streptococcal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>pneumonia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>pneumonia mycoplasmal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>relapsing fever</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Rhinovirus infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Scarlet Fever</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Sinusitis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Staphylococcal skin infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="226"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Streptococcal infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="226"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Sweating fever</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Tinea infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Tonsillitis streptococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Tooth Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="226"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Varicella</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Viral Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Viral Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Viral Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Viral Upper Respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Animal Bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Foreign body in eye</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>hand fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>head injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>incision site pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>infection with unknown anc - bladder (urinary)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>laceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>muscle injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>nasal cavity/paranasal sinus reactions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>post procedural complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>postoperative fever</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>road traffic accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood Glucose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>electroencephalogram abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Emergency care examination normal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Heart rate irregular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Tympanometry</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus non-insulin dependent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Growing pains</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>neck pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Torticollis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>hypersomnia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>loss of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Sinus headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Attention Deficit/Hyperactivitiy disorder</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="226"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Enuresis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Urinary tract pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>genital rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Allergic rhinitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Asthmatic crisis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Choking sensation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="226"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Croup Non infectious</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>nasal congestion</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="226"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>postnasal drip</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>productive cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>pulmonary congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Rhinitis seasonal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Sleep Apnea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Snoring</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Throat irritation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="226"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Tonsillar haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract congestion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="226"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract inflammation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>vasomotor rhinitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>rash</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Ear Piercing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Ear Tube removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Finger nail removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>pain management</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="226"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="227"/>
              </event>
              <event>
                <sub_title>Tongue Tie operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="226"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="227"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Children under 5 years of age, in whom OSAS is common, were not included. Children on medications for ADHD or with prolonged oxygen-hemoglobin desaturation were also excluded, so results cannot be extrapolated to such children.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Susan S. Ellenberg</name_or_title>
      <organization>University of Pennsylvania</organization>
      <phone>215-573-3904</phone>
      <email>sellenbe@upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

